Asset profile

Ebstrocel · INmune Bio Inc. (INMB)

Indication
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Also known as
CORDStrom, Ebstrocel™, pobistrocel
CompanyINMBINmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The compan…

More from INmune Bio Inc.

Other drugs and candidates from the same company tracked in this sector.

Ebstrocel · INmune Bio Inc. (INMB) — FDA Timeline & Readiness Checklist | SimianX AI